Condition
Subconjunctival Hemorrhage
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07247071CompletedPrimary
Modifiable Risk Factors for Non-traumatic Subconjunctival Hemorrhage
NCT04827836Not ApplicableCompleted
Pain Control and Subconjunctival Hemorrhage Size After Intravitreal Injection
NCT04683159Not ApplicableUnknown
Brimonidine Tartrate for Pterygium Surgery
NCT04633954Not ApplicableCompletedPrimary
Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery
NCT04400916Not ApplicableUnknownPrimary
Topical Tranexamic Acid After Intravitreal Injections
Showing all 5 trials